trial · primary record
Celecoxib + Acetaminophen
Joint Pain
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 231 |
| Primary completion | 2025-11-30 |
| Primary endpoint | Comparison of the proportion of patients in each treatment group who, based on the baseline assessment, achieved a response according to the OMERACT-OARSI criteria at Weeks 1, 2, 4, and 6 of follow-up. |
| Registry ID | NCT06863636 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:22.230Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06863636
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.